Literature reference · Endocrinology

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

PubMed · Retrieved 2026-10-13

Bibliographic record: The New England journal of medicine (2023 Dec 14). PMID 37952131. DOI 10.1056/NEJMoa2307563.

View original source ↗

Reference details

Authors
A Michael Lincoff; Kirstine Brown-Frandsen; Helen M Colhoun; John Deanfield; Scott S Emerson; Sille Esbjerg; Søren Hardt-Lindberg; G Kees Hovingh; Steven E Kahn; Robert F Kushner; Ildiko Lingvay; Tugce K Oral; Marie M Michelsen; Jorge Plutzky; Christoffer W Tornøe; Donna H Ryan; SELECT Trial Investigators
Journal
The New England journal of medicine
Publication date
2023 Dec 14
PMID
37952131
DOI
10.1056/NEJMoa2307563
Volume
389
Issue
24
Pages
2221
Language
eng
Publication types
Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH subjects
Humans; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Glucagon-Like Peptides; Hypoglycemic Agents; Myocardial Infarction; Obesity; Overweight; Stroke; Glucagon-Like Peptide-1 Receptor Agonists; Cardiovascular Agents; Semaglutide

Citation

A Michael Lincoff; Kirstine Brown-Frandsen; Helen M Colhoun; John Deanfield; Scott S Emerson; Sille Esbjerg; Søren Hardt-Lindberg; G Kees Hovingh; Steven E Kahn; Robert F Kushner; Ildiko Lingvay; Tugce K Oral; Marie M Michelsen; Jorge Plutzky; Christoffer W Tornøe; Donna H Ryan; SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.. The New England journal of medicine. 2023 Dec 14.

Indexed subjects

Humans • Cardiovascular Diseases • Diabetes Mellitus, Type 2 • Double-Blind Method • Glucagon-Like Peptides • Hypoglycemic Agents • Myocardial Infarction • Obesity • Overweight • Stroke • Glucagon-Like Peptide-1 Receptor Agonists • Cardiovascular Agents • Semaglutide

Access and reuse

This page presents bibliographic facts and links from the PubMed record. The publisher abstract and full article are not reproduced. Follow the source links to read the research and check its current status.

Sources and reuse

Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-06-18. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.

Related references in Endocrinology

Medical terminology Endocrinology

Anovulation

Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.

Medical entity reference Endocrinology

adrenogenital disease

Human disease. Wikidata entity Q13368382; linked MeSH descriptor D047808. Includes multilingual names and external identifier mappings.

Health topic Endocrinology

Diabetes Type 1

Diabetes means your blood glucose, also called blood sugar, is too high. With type 1 diabetes, your body makes little or no insulin. Insulin is a hormone from your pancreas that helps glucose move from your body into your cells, where…

Genetics reference Endocrinology

Type 1 diabetes

Type 1 diabetes is a disorder characterized by abnormally high levels of blood glucose, also called blood sugar. In this form of diabetes, specialized cells in the pancreas called beta cells stop producing insulin. Insulin controls…

MedlinePlus GeneticsRead reference →